Abstract
The case is reported of a man developing drug-induced systemic lupus erythematosus while taking hydralazine. The illness was characterized by arthritis and a purpuric rash particularly in the light-sensitive areas as well as orogenital and cutaneous ulceration. Anti-nuclear antibody and DNA binding were positive. All clinical manifestations disappeared on withdrawal of hydralazine.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Deldieu F., Job C. H., Martin J. L., Chouraki L., Delbarre F. Association d'une maladie lupique et d'une maladie de Behçet. Nouv Presse Med. 1977 Dec 31;6(45):4204–4204. [PubMed] [Google Scholar]
- Harland S. J., Facchini V., Timbrell J. A. Hydrallazine-induced lupus erythematosus-like syndrome in a patient of the rapid acetylator phenotype. Br Med J. 1980 Jul 26;281(6235):273–274. doi: 10.1136/bmj.281.6235.273-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Strandberg I., Boman G., Hassler L., Sjöqvist F. Acetylator phenotype in patients with hydralazine-induced lupoid syndrome. Acta Med Scand. 1976;200(5):367–371. doi: 10.1111/j.0954-6820.1976.tb08248.x. [DOI] [PubMed] [Google Scholar]
- Ullman S., Wiik A., Kobayasi T., Halberg P. Drug-induced lupus erythematosus syndrome. Immuno-pathological, electronmicroscopical and serological studies. Acta Derm Venereol. 1974;54(5):387–390. [PubMed] [Google Scholar]